Inventor · disambiguated record
Gregory R. Moe
Also filed as: MOE GREGORY · MOE GREGORY R
21 granted patents·4 pending applications·207 citations·filing 1983–2023
94Inventor score
Files withMOE GREGORY R8CHIRON CORP3CHILDRENS HOSPITAL & RES CENTER AT OAKLAND2NOVARTIS VACCINES & DIAGNOSTIC2OMVAX INC2
Top patents by PatentIndex Score
25 records- 0193US6936261B2Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidisCHILDRENS HOSP & RES CT OAK·Filed 2001·Granted Aug 30, 2005·40 cites·32 claims
- 0291US7595307B2Polysaccharide derivatives and uses in induction of an immune responseCHILDREN S HOSPITAL AND RES CT·Filed 2005·Granted Sep 29, 2009·10 cites·36 claims
- 0387US8148335B2De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapyMOE GREGORY R·Filed 2006·Granted Apr 3, 2012·9 cites·23 claims
- 0487US6048527AAntibodies that define unique Meningococcal B epitopes and vaccine compositionsCHIRON CORP·Filed 1997·Granted Apr 11, 2000·61 cites·4 claims
- 0584US7534444B2Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodiesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2002·Granted May 19, 2009·9 cites·18 claims
- 0680US9872921B2DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapyCHILDREN'S HOSPITAL & RES CENTER OAKLAND·Filed 2015·Granted Jan 23, 2018·2 cites·31 claims
- 0780US8642562B2Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targetingMOE GREGORY R·Filed 2011·Granted Feb 4, 2014·6 cites·19 claims
- 0880US6642354B2Molecular mimetics of unique Neisseria meningitidis serogroup B epitopesCHIRON CORP·Filed 2001·Granted Nov 4, 2003·9 cites·7 claims
- 0977US9089513B2De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapyMOE GREGORY R·Filed 2012·Granted Jul 28, 2015·2 cites·4 claims
- 1076US9333247B2Oligosialic acid derivatives, methods of manufacture, and immunological usesMOE GREGORY R·Filed 2008·Granted May 10, 2016·3 cites·17 claims
- 1171US2010068728A1Polysaccharide derivatives and uses in induction of an immune responseMOE GREGORY R·Filed 2009·Application pending·0 cites
- 1268US6030619AMolecular mimetics of meningococcal B epitopesCHIRON CORP·Filed 1998·Granted Feb 29, 2000·33 cites·19 claims
- 1367US11065341B2DE-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapyCHILDRENS HOSPITAL & RES CENTER AT OAKLAND·Filed 2017·Granted Jul 20, 2021·0 cites·20 claims
- 1466US7063949B2Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopesCHILDRENS HOSP MEDICAL CENTER·Filed 2003·Granted Jun 20, 2006·4 cites·4 claims
- 1562US2025206840A1DE-N-ACETYLATED POLYSIALIC ACID (dPSA) BINDING AGENT AND METHOD OF USING SAMESACCHARO INC·Filed 2023·Application pending·0 cites
- 1659US8980285B2Vaccines for broad spectrum protection against Neisseria meningitidisGRANOFF DAN M·Filed 2005·Granted Mar 17, 2015·0 cites·7 claims
- 1758US8097591B2Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targetingMOE GREGORY R·Filed 2008·Granted Jan 17, 2012·0 cites·25 claims
- 1854US8642733B2T-cell stimulating protein B and methods of useMOE GREGORY R·Filed 2010·Granted Feb 4, 2014·0 cites·29 claims
- 1953US4663309ANovel peptide hormones with calcitonin-like activityUNIVERSITY PATENTS INC·Filed 1984·Granted May 5, 1987·13 cites·25 claims
- 2053US2023256072A1Compositions and methods for vaccination against neisseria gonorrhoeaeOMVAX INC·Filed 2023·Application pending·0 cites
- 2151US2023226174A1Sars-cov-2 receptor binding domain in native outer membrane vesiclesOMVAX INC·Filed 2023·Application pending·0 cites
- 2248US8999954B2Inhibitors of polysialic acid de-N-acetylase and methods for using the sameMOE GREGORY R·Filed 2008·Granted Apr 7, 2015·0 cites·15 claims
- 2345US4514331APeptide hormones with calcitonin-like activityUNIVERSITY PATENTS INC·Filed 1983·Granted Apr 30, 1985·6 cites·2 claims
- 2443US10576137B2Oligosialic acid derivatives, methods of manufacture, and immunological usesCHILDRENS HOSPITAL & RES CENTER AT OAKLAND·Filed 2016·Granted Mar 3, 2020·0 cites·17 claims
- 2538US7504254B2Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Mar 17, 2009·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →